Clinical Trial Update: Regular Use Effect of Inhaled Ipratropium Bromide on Airway Responsiveness to Methacholine in Well-controlled Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial updating on regular inhaled ipratropium bromide for airway responsiveness to methacholine in well-controlled asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

Sponsor: University of Saskatchewan | Conditions: Asthma | Phase 4 | Status: COMPLETED